Page 2 - Johnc Klock News Today

Great Lakes Advisors LLC acquired a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 2,406 shares of the biotechnology company’s stock, valued at approximately $249,000. Other institutional investors and hedge funds have also added […]

Intech Investment Management LLC raised its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 13.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 14,909 shares of the biotechnology company’s stock after acquiring an additional 1,811 shares during the period. Intech Investment Management LLC’s holdings in BioMarin Pharmaceutical were […]

Prudential PLC lifted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 94.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,429 shares of the biotechnology company’s stock after buying an additional 3,599 shares during the quarter. Prudential PLC’s holdings […]

Qsemble Capital Management LP acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 8,100 shares of the biotechnology company’s stock, valued at approximately $838,000. Several other hedge funds also recently added to or reduced their stakes in BMRN. Altshuler Shaham Ltd […]

Fiera Capital Corp reduced its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 0.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 461,108 shares of the biotechnology company’s stock after selling 254 shares during the quarter. Fiera Capital Corp […]

Skandinaviska Enskilda Banken AB publ increased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 155.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 192,385 shares of the biotechnology company’s stock after acquiring an additional 117,079 shares […]

Skandinaviska Enskilda Banken AB publ boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 155.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 192,385 shares of the biotechnology company’s stock after purchasing an additional 117,079 shares during the period. Skandinaviska Enskilda Banken […]

Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) have been assigned an average recommendation of “Hold” from the twenty-six ratings firms that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and nine have given a buy recommendation […]

Robeco Institutional Asset Management B.V. lessened its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 47.4% in the 4th quarter, Holdings Channel reports. The institutional investor owned 30,265 shares of the biotechnology company’s stock after selling 27,269 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in BioMarin Pharmaceutical were […]

StockNews.com upgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Get Rating) from a hold rating to a buy rating in a report published on Friday. Other equities analysts have also recently issued research reports about the company. Credit Suisse Group increased their target price on BioMarin Pharmaceutical from $110.00 to $127.00 and gave the company an […]